Differences in the recovery of platelet counts after biological aortic valve replacement

Interactive Cardiovascular and Thoracic Surgery

Volumn 8, Issue 1, 2009, Pages 70-73

  Hilker, Lutz ^a,c   Wodny, Michael ^b   Ginesta, Mario ^a   Wollert, Hans Georg ^a   Eckel, Lothar ^a  

^a Heart and Diabetes Center Mecklenburg Vorpommern   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

^c Herz und Diabeteszentrum Mecklenburg/Vorpommern   (Germany)

Author keywords

Biological valve replacement; Platelets; Stentless prostheses

Indexed keywords

AGE DISTRIBUTION; AGED; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; CARPENTIER EDWARDS BIOPROSTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY DISEASE; ENDOCARDITIS; EXTRACORPOREAL CIRCULATION; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THROMBOCYTE COUNT; TRICUSPID VALVE DISEASE;

AGE FACTORS; AGED; ANTICOAGULANTS; AORTIC VALVE; BIOPROSTHESIS; EXTRACORPOREAL CIRCULATION; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN; HUMANS; MALE; PLATELET COUNT; PROSTHESIS DESIGN; RETROSPECTIVE STUDIES; STENTS; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 58149386005     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2008.188524     Document Type: Conference Paper

References (8)

1. Beholz S, Liu J, Dushe S, Konertz WF. The Freedom Solo Valve: superior hemodynamic results with a new stentless pericardial valve in aortic valve replacement. J Heart Valve Dis 2007, Jan;16:49-55.
2. Le Guyader A, Watanabe R, Berbe J, Boumediene A, Cogne M, Laskar M. Platelet activation after aortic prosthetic valve surgery. Interact CardioVasc Surg 2006;5:60-64.
3. Lehner G, Fischlein T, Baretton G, Murphy JG, Reichart B. Endothelialized biological heart valve prostheses in the non-human primate model. Eur J Cardiothorac Surg 1997;11:498-504.
4. Geiser T, Sturzenegger M, Genewein U, Haberli A, Beer JH. Mechanisms of cerebrovascular events as assessed by procoagulant activity, cerebral micro emboli, and platelet micro particles in patients with prosthetic heart valves. Stroke 1998;29:1770-1777.
5. Nieuwland R, Berckmans RJ, Rotteveel-Eijkan RC, Maquelin KN, Roozendaal KJ, Jansen PG, Ten Have K, Eijsman L, Hack CE, Sturk A. Cell-derived micro particles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541.
6. Cohen Z, Gonzales RF, Davis-Gorman GF, Copeland JG, Mc Donagh PF. Thrombin activity and platelet micro particle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 2002;107:217-221.
7. Grubitzsch H, Linneweber J, Kossagk C, Sanli E, Beholz S, Konertz WF. Aortic valve replacement with new-generation stentless pericardial valves: short-term clinical and hemodynamic results. J Heart Valve Dis. 2005 Sep;14:623-629.
8. Beholz S, Konertz WF. Avoiding early partial valve thrombosis of the Pericarbon Freedom stentless valve. J Heart Valve Dis 2007 Jan;16:91-92.